Patents by Inventor John A. McIntyre

John A. McIntyre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9169317
    Abstract: The binding specificity of at least one plasma protein suspended or dissolved in a liquid medium is altered by exposing the protein to an oxidizing agent or an electric current sufficient to alter its binding specificity. A masked protein such as an autoantibody can be recovered from blood or blood products or extracts by oxidizing the protein to change its binding specificity.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: October 27, 2015
    Assignee: Redox-Reactive Reagents, LLC
    Inventor: John A. McIntyre
  • Publication number: 20150275896
    Abstract: A rotary pump device includes a stator chamber with a cylindrical inner wall having intake and exhaust ports and an abutment mounted therein, and a rotor eccentrically mounted on an axial driven shaft for rotation within the chamber. The rotor keeps continuous wiping contact with the chamber wall while repelling magnets exert pressure on an abutment which maintains contact with the rotor to partition the intake and outlet ports. The repelling magnets act as a spring to assure contact of the abutment on the rotor while the pump is running or on standby. The repelling is caused by locating magnets positioned with similar facing poles in a pocket positioned against an abutment. A full intake/exhaust cycle takes place every 360° of rotor travel.
    Type: Application
    Filed: March 26, 2014
    Publication date: October 1, 2015
    Inventor: John McIntyre
  • Publication number: 20150148288
    Abstract: New insecticidal proteins, nucleotides, peptides, their expression in plants, methods of producing the peptides, new processes, production techniques, new peptides, new formulations, and new organisms, a process which increases the insecticidal peptide production yield from yeast expression systems. The present invention is also related and discloses selected endotoxins we call cysteine rich insecticidal peptides (CRIPS) which are peptides derived from Bacillus thuringiensis (Bt) and their genes and endotoxins in combination with toxic peptides known as Inhibitor Cystine Knot (ICK) genes and peptides as well as with other types of insecticidal peptides such as trypsin modulating oostatic factor (TMOF) peptide sequences used in various formulations and combinations; of both genes and peptides, useful for the control of insects.
    Type: Application
    Filed: March 8, 2013
    Publication date: May 28, 2015
    Inventors: Robert M. Kennedy, William Tedford, Christopher Hendrickson, Robert Venable, Catherine Foune, John McIntyre, Alvar Carlson, Lin Bao
  • Patent number: 9011123
    Abstract: A rotary pump device includes a stator chamber with a cylindrical inner wall having intake and exhaust ports and a swinging abutment mounted therein, and a rotor eccentrically mounted on an axial drive shaft for rotation within the chamber. The rotor keeps continuous wiping contact with the chamber wall while the swinging abutment maintains contact with the rotor to partition the intake and outlet ports. In a single abutment configuration, a full intake/exhaust cycle occurs every 360° of rotor travel.
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: April 21, 2015
    Inventor: John McIntyre
  • Publication number: 20140291078
    Abstract: A novel brake assembly is provided for a bicycle. The assembly is comprised of an arrangement of a pair of pulleys attached to braking arms with affixed brake pads leveraged against the bicycle rim. The braking power is accentuated by employing the two pulleys on the braking arms. A return spring causes the arms to return to non-braking position in response to the release of the braking cable.
    Type: Application
    Filed: March 29, 2013
    Publication date: October 2, 2014
    Inventor: John McIntyre
  • Publication number: 20140187478
    Abstract: Procedures are described which use solvents to increase the topical insecticidal activity of toxic insect peptides. These procedures comprise drying the peptides, if needed, followed by the addition of either: 1) a polar organic solvent, with or without water, to a dried peptide, or 2) the addition of polar aprotic solvent or other adjuvant to the dried peptide, followed by the addition of either: 1) a polar organic solvent, with or without water, (where a polar aprotic solvent is added first) or 2) a polar aprotic solvent or other adjuvant to the peptide polar organic solvent (where the polar organic solvent is added first), to the peptide formulation.
    Type: Application
    Filed: March 7, 2014
    Publication date: July 3, 2014
    Applicant: Vestaron Corporation
    Inventors: William Tedford, John McIntyre, Daniel Russell, Peter Carlson
  • Publication number: 20140134931
    Abstract: The present concept a wet abrasive blasting system includes a splitter manifold receiving compressed air from a source of compressed air. The splitter manifold includes at least two passageways and also a manifold pre-nozzle associated with each passageway respectively. The splitter manifold communicates air through the passageways to corresponding air conduits which feed compressed air to at least two wet blasters respectively wherein the blasters each include an exit nozzle which are substantially the same or smaller in size than the pre-nozzles.
    Type: Application
    Filed: October 11, 2013
    Publication date: May 15, 2014
    Inventor: John McIntyre
  • Patent number: 8703910
    Abstract: Procedures are described which use solvents to increase the topical insecticidal activity of toxic insect peptides. These procedures comprise drying the peptides, if needed, followed by the addition of either: 1) a polar organic solvent, with or without water, to a dried peptide, or 2) the addition of polar aprotic solvent or other adjuvant to the dried peptide, followed by the addition of either: 1) a polar organic solvent, with or without water, (where a polar aprotic solvent is added first) or 2) a polar aprotic solvent or other adjuvant to the peptide polar organic solvent (where the polar organic solvent is added first), to the peptide formulation.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: April 22, 2014
    Assignee: Vestaron Corproation
    Inventors: William Tedford, John McIntyre, Daniel Russell, Peter Carlson
  • Publication number: 20130276757
    Abstract: This internal combustion engine utilizes a rotary piston motion simultaneously having an upward and downward stroke to facilitate a power output. In comparison to existing engines, this engine possesses fewer parts, has enhanced fuel economy and performance, and is capable of using alternative fuels. The drive shaft is connected directly to the piston and a fixed arm is attached to the driveshaft. The fixed arm has a rotating bushing traversing upon an inclined bearing surface to allow rotary and reciprocating motion of the piston.
    Type: Application
    Filed: April 20, 2012
    Publication date: October 24, 2013
    Inventor: John McIntyre
  • Patent number: 8501684
    Abstract: Procedures are described which use solvents to increase the topical insecticidal activity of toxic insect peptides. These procedures comprise drying the peptides, if needed, followed by the addition of either: 1) a polar organic solvent, with or without water, to a dried peptide, or 2) the addition of polar aprotic solvent or other adjuvant to the dried peptide, followed by the addition of either: 1) a polar organic solvent, with or without water, (where a polar aprotic solvent is added first) or 2) a polar aprotic solvent or other adjuvant to the peptide polar organic solvent (where the polar organic solvent is added first), to the peptide formulation.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: August 6, 2013
    Assignee: Vestaron Corporation
    Inventors: William Tedford, John McIntyre, Daniel Russell, Peter Carlson
  • Publication number: 20130017992
    Abstract: Procedures are described which use solvents to increase the topical insecticidal activity of toxic insect peptides. These procedures comprise drying the peptides, if needed, followed by the addition of either: 1) a polar organic solvent, with or without water, to a dried peptide, or 2) the addition of polar aprotic solvent or other adjuvant to the dried peptide, followed by the addition of either: 1) a polar organic solvent, with or without water, (where a polar aprotic solvent is added first) or 2) a polar aprotic solvent or other adjuvant to the peptide polar organic solvent (where the polar organic solvent is added first), to the peptide formulation.
    Type: Application
    Filed: June 20, 2012
    Publication date: January 17, 2013
    Applicant: Vestaron Corporation
    Inventors: William Tedford, John McIntyre, Daniel Russell, Peter Carlson
  • Patent number: 8334146
    Abstract: The binding specificity of at least one plasma protein suspended or dissolved in a liquid medium is altered by exposing the protein to an oxidizing agent or an electric current sufficient to alter its binding specificity. A masked protein such as an autoantibody can be recovered from blood or blood products or extracts by oxidizing the protein to change its binding specificity.
    Type: Grant
    Filed: April 23, 2008
    Date of Patent: December 18, 2012
    Assignee: Redox-Reactive Reagents LLC
    Inventor: John A. McIntyre
  • Patent number: 8217003
    Abstract: Procedures are described which use solvents to increase the topical insecticidal activity of toxic insect peptides. These procedures comprise drying the peptides, if needed, followed by the addition of either: 1) a polar organic solvent, with or without water, to a dried peptide, or 2) the addition of polar aprotic solvent or other adjuvant to the dried peptide, followed by the addition of either: 1) a polar organic solvent, with or without water, (where a polar aprotic solvent is added first) or 2) a polar aprotic solvent or other adjuvant to the peptide polar organic solvent (where the polar organic solvent is added first), to the peptide formulation.
    Type: Grant
    Filed: September 28, 2009
    Date of Patent: July 10, 2012
    Assignee: Vestaron Corporation
    Inventors: William Tedford, John McIntyre, Daniel Hopkins Russell, Peter Carlson
  • Publication number: 20120107841
    Abstract: A laboratory method for screening, diagnosing, monitoring and/or staging early onset Alzheimer's disease which consists of mild cognitive impairment entails conducting a blood test after an oxidative exposure of serum to assay for the presence of an elevated level of redox-reactive autoantibodies.
    Type: Application
    Filed: July 19, 2011
    Publication date: May 3, 2012
    Inventor: John A. McIntyre
  • Patent number: 8118578
    Abstract: A rotary pump device includes a stator chamber with a cylindrical inner wall having intake and exhaust ports therein, and a two-part, expanding rotor eccentrically mounted for rotation within the chamber. The rotor comprises two crescentoid bodies with end surfaces in sliding, mating contact. A spring rod is placed between the inner rotor body surfaces to maintain rotor contact points in continuous wiping contact with the chamber wall. A full intake/exhaust cycle occurs every 180° of rotor travel.
    Type: Grant
    Filed: December 12, 2008
    Date of Patent: February 21, 2012
    Inventor: John McIntyre
  • Publication number: 20110288469
    Abstract: A surgical device is provided for both ablating a channel in a patient's tissue and also delivering a therapeutic agent. The device includes an elongated multi-lumen tube, an elongated tissue ablating assembly, and a therapeutic agent delivery assembly. The therapeutic agent is capable of being delivered into the channel and/or to the surrounding tissue. The device may further include a second multi-lumen tube also capable of delivering therapeutic agents. A method is also provided for using such a surgical device to ablate a channel in a patient's tissue and also deliver a therapeutic agent to the tissue, for example, for transmyocardial revascularization or other procedures.
    Type: Application
    Filed: July 29, 2011
    Publication date: November 24, 2011
    Applicant: CARDIOGENESIS CORPORATION
    Inventors: John McIntyre, Elbert Tzeng
  • Patent number: 8062354
    Abstract: A tape-reinforced tubular vascular graft formed of sintered fluoropolymer(s), such as expanded, sintered PTFE. The graft includes a base graft and a reinforcing tape applied thereto. The tape may be spirally wrapped about the graft or spirally wrapped into a tube about a cylindrical mandrel and then applied to the exterior of the graft. Radial shrinkage of the combined base graft and tape, or of the reinforcing tape tube, renders the vascular graft subsequently radially enlargeable by more than 5%, without tearing or breaking of the reinforcement tape layer of the graft. Radially enlargeable grafts of the present invention may be combined with various types of stents or anchoring systems, to form endovascular graft devices which are transluminally insertable and implantable within the lumen of a host blood vessel.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: November 22, 2011
    Assignee: Edwards Lifesciences Corporation
    Inventors: Donald Shannon, John McIntyre, Chris Kuo, Chris McCollam, Robert Peterson
  • Patent number: 8012096
    Abstract: The present invention contemplates a surgical device for both ablating a channel in a patient's tissue and also delivering a therapeutic agent. The device includes an elongated multi-lumen tube, an elongated tissue ablating assembly, and a therapeutic agent delivery assembly. The therapeutic agent is capable of being delivered into the channel and/or to the surrounding tissue. The device may further include a second multi-lumen tube also capable of delivering therapeutic agents. Although suitable for many operations, the device is particularly well suited for transmyocardial revascularization operations. The present invention also contemplates a procedure for using such a surgical device to ablate a channel in a patient's tissue and also deliver a therapeutic agent.
    Type: Grant
    Filed: October 5, 2006
    Date of Patent: September 6, 2011
    Assignee: Cardiogenesis Corporation
    Inventors: John McIntyre, Elbert Tzeng
  • Patent number: 7989596
    Abstract: The binding specificity of a monoclonal antibody is altered by exposing the monoclonal antibody to an oxidizing agent or an electric potential.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: August 2, 2011
    Assignee: Redox-Reactive Reagents LLC
    Inventor: John A. McIntyre
  • Patent number: 7892751
    Abstract: A neurodegenerative disease or condition is diagnosed in a subject by obtaining a sample of cerebral spinal fluid from the subject and assaying the sample by an assay method that detects the presence of at least one antiphospholipid autoantibody in the sample, wherein an elevated level of at least one antiphospholipid autoantibody in the sample of cerebral spinal fluid correlates with a neurodegenerative disease or condition in the subject. The neurodegenerative disease or condition may also be diagnosed by assaying a sample of cerebral spinal fluid to detect nitrosylated antibodies, wherein an elevated level of nitrosylated antibodies correlates with a neurodegenerative disease or condition in said subject.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: February 22, 2011
    Assignee: Redox-Reactive Reagents LLC
    Inventor: John A. McIntyre